Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

1,007 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,007 results

Large-scale testing (Phase 3)Study completedNCT05136885
What this trial is testing

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Early research (Phase 1)Study completedNCT01449578
What this trial is testing

Dexpramipexole SAD/MAD Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 63
Testing effectiveness (Phase 2)Study completedNCT00925847
What this trial is testing

Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 23
Not applicableUnknownNCT04240925
What this trial is testing

Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease

Who this might be right for
Motor Neuron DiseaseRespiratory FailureAmyotrophic Lateral Sclerosis
Ospedale San Raffaele 44
Not applicableStudy completedNCT00847847
What this trial is testing

Neuromuscular Transmission in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 14
Early research (Phase 1)UnknownNCT02881476
What this trial is testing

Therapeutic Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Warmia and Mazury 30
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Not applicableStudy completedNCT03487536
What this trial is testing

Nutritional Prognostic Factors in ALS

Who this might be right for
Nutritional DeficiencyNeuro-Degenerative DiseaseGastrostomy
University of Bari 47
Not applicableWithdrawnNCT03034317
What this trial is testing

NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Synapse Biomedical
Early research (Phase 1)Study completedNCT01771640
What this trial is testing

Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Royan Institute 8
Testing effectiveness (Phase 2)Study completedNCT04840823
What this trial is testing

Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
McGill University 8
Not applicableLooking for participantsNCT05370079
What this trial is testing

Control Cohort CTRL COH

Who this might be right for
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Hospices Civils de Lyon 350
Not applicableLooking for participantsNCT07312240
What this trial is testing

LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Istituto Auxologico Italiano 140
Not applicableUnknownNCT03377868
What this trial is testing

Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
American University of Beirut Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT03705390
What this trial is testing

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University of Birmingham 11
Not applicableLooking for participantsNCT06681610
What this trial is testing

Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Parc de Salut Mar 50
Not applicableLooking for participantsNCT07257302
What this trial is testing

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
National Center of Neurology and Psychiatry, Japan 25
Not applicableLooking for participantsNCT06578195
What this trial is testing

ASSESS ALL ALS Study

Who this might be right for
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix 2,000
Not applicableLooking for participantsNCT05137665
What this trial is testing

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Who this might be right for
Amyotrophic Lateral SclerosisMovement DisordersDegenerative Disorder+1 more
Target ALS Foundation, Inc. 1,000
Testing effectiveness (Phase 2)Study completedNCT04788745
What this trial is testing

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
The University of Queensland 21
Next Page